v3.26.3
Summary of Significant Accounting Policies (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Summary Of Significant Accounting Policies    
Summary of Changes in Allowance for Credit Losses

The following table presents changes in the allowance for credit losses for the six months ended June 30, 2026:

 

      
Balance at December 31, 2025  $41 
Change in provision for credit losses   (35)
Balance at June 30, 2026  $6 

The following table presents changes in the allowance for credit losses for the year ended December 31, 2025:

 

       
Balance - December 31, 2024   $24,210 
Change in provision for credit losses    17,131 
Balance - December 31, 2025   $41,341 
Schedule of Basic and Diluted Net Loss Per Share

The calculation of basic and diluted net loss per share attributable to common stock was as follows:

 

  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2026   2025   2026   2025 
Numerator:                    
Net loss attributable to common shareholders—basic and diluted  $(4,965)  $(7,928)  $(13,382)  $(11,572)
                     
Denominator:                    
Weighted average shares—basic and diluted (in thousands)   163    10    118    8 
Net loss per share attributable to common shareholders—basic and diluted  $(30.46)  $(792.80)  $(113.41)  $(1,446.50)

The calculation of basic and diluted net loss per share attributable to common stock was as follows:

 

   For the Year Ended December 31, 
   2025   2024 
Numerator:          
Net loss attributable to common shareholders—basic and diluted  $(22,492,075)  $(31,095,029)
           
Denominator:          
Weighted average shares—basic and diluted   18,915    2,229 
Net loss per share attributable to common shareholders—basic and diluted  $(1,189.11)  $(13,950.21)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss that could potentially be dilutive in future periods are as follows:

 

   2026   2025 
   As of June 30, 
   2026   2025 
Options   67    63 
RSUs   2,292    1,082 
Public warrant shares   115    115 
GEM warrant shares   8    8 
Common warrant shares   58,264    2,800 
Placement agent warrant shares   22,307    159 
Total   83,053    4,227 

Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss that could potentially be dilutive in future periods are as follows:

 

         
  As of December 31, 
   2025   2024 
Options   63    13 
RSUs   2,070    170 
Public warrant shares   115    115 
GEM warrant shares   8    8 
Common warrant shares   3,680    2,264 
Placement agent warrant shares   359    53 
Pre-funded warrants   —    — 
Total   6,295    2,623